Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aradigm Corp (ARDM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,826
  • Shares Outstanding, K 15,220
  • Annual Sales, $ 14,470 K
  • Annual Income, $ -10,710 K
  • 36-Month Beta 2.46
  • Price/Sales 1.32
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/22/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0701 +71.18%
on 02/19/19
0.8001 -85.00%
on 01/22/19
-0.4900 (-80.33%)
since 01/18/19
3-Month
0.0701 +71.18%
on 02/19/19
1.2500 -90.40%
on 12/11/18
-0.8700 (-87.88%)
since 11/19/18
52-Week
0.0701 +71.18%
on 02/19/19
2.3300 -94.85%
on 06/20/18
-1.1800 (-90.77%)
since 02/16/18

Most Recent Stories

More News
Aradigm Announces Receipt of Final FDA Minutes for the Type B Meeting on January 25, 2019

Aradigm Corporation (Pink Market: ARDM) ("Aradigm" or the "Company").

ARDM : 0.1200 (-73.91%)
Aradigm Announces Detailed Third Party Evaluation Results for Apulmiq (FDA)/Linhaliq (EMA)

Aradigm Corporation (OTCQB: ARDM) ("Aradigm" or the "Company") today announced specific, detailed results of an independent third party evaluation (TPE) of the Phase 3 clinical trial results...

ARDM : 0.1200 (-73.91%)
Aradigm Announces Results of Third Party Verification for Apulmiq (formerly Linhaliq)

SOURCE: Aradigm Corporation

ARDM : 0.1200 (-73.91%)
Aradigm Announces Third Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the third quarter and nine months ended September 30, 2018.

ARDM : 0.1200 (-73.91%)
Aradigm Announces First Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the first quarter and three months ended March 31, 2018.

ARDM : 0.1200 (-73.91%)
New Research Coverage Highlights Aradigm, Ultra Petroleum, TRI Pointe Group, Finisar, Tesla, and The Progressive -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aradigm Corporation (NASDAQ:ARDM),...

UPL : 0.70 (-1.41%)
TSLA : 293.02 (+0.61%)
ARDM : 0.1200 (-73.91%)
FNSR : 24.07 (+0.59%)
PGR : 71.98 (-0.18%)
TPH : 13.25 (+0.23%)
Wired News - EMA Completed Validation of MAA for Aradigm's Linhaliq in Non-Cystic Fibrosis Bronchiectasis

Stock Monitor: Bio-Path Holdings Post Earnings Reporting

ARDM : 0.1200 (-73.91%)
BPTH : 2.18 (-0.46%)
Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced the completed formal validation by the European Medicines Agency (EMA) of the Marketing Authorisation Application (MAA)...

ARDM : 0.1200 (-73.91%)
Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results

--Cash and cash equivalents of $7.1 million expected to be sufficient to fund operations for Q1 2018; temporary measures implemented to preserve cash resources

ARDM : 0.1200 (-73.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ARDM with:

Key Turning Points

2nd Resistance Point 0.4599
1st Resistance Point 0.2900
Last Price 0.1200
1st Support Level 0.0101
2nd Support Level 0.0000

See More

52-Week High 2.3300
Fibonacci 61.8% 1.4667
Fibonacci 50% 1.2000
Fibonacci 38.2% 0.9334
Last Price 0.1200
52-Week Low 0.0701

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar